Responses
Regular and Young Investigator Award Abstracts
Cell Therapies
250 Chimeric antigen receptors containing CD30-derived costimulatory domain elicit augmented T cell effector functions and anti-tumor efficacy
Compose a Response to This Article
Other responses
No responses have been published for this article.